Glonghui, May 15 | Hongbo Pharmaceutical fell more than 9%, Blue Biotech fell more than 7%, and Canaan Technology, Shuangcheng Pharmaceutical, and Xintiandi followed suit.
A股CRO概念普跌 泓博医药跌超9%
A-share CRO concepts generally fell, Hongbo Pharmaceutical fell more than 9%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.